JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krayer, O.
Right arrow Articles by Paasonen, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krayer, O.
Right arrow Articles by Paasonen, M. K.
Journal of Pharmacology And Experimental Therapeutics, Vol. 135, Issue 2, 164-173, 1962
Copyright © 1962 by American Society for Pharmacology and Experimental Therapeutics


ACTION OF GUANETHIDINE AND RESERPINE UPON THE ISOLATED MAMMALIAN HEART

O. Krayer 1, M. H. Alper 1, and M. K. Paasonen 2

1 Department of Pharmacology, Harvard Medical School, Boston, Massachusetts
2 Department of Pharmacology, University of Helsinki, Helsinki, Finland

Guanethidine was studied in the heart-lung preparation of normal and reserpine-pretreated dogs (0.5 mg/kg, 48 and 24 hours prior to isolation of the heart). In the normal heart it had a rate-increasing effect which, in the dose range of 1 to 30 mg, lasted for more than 2 hours. The intensity of the effect upon the pacemaker of the heart was due to norepinephrine release and to an acute increase in sensitivity of the pacemaker to norepinephrine caused by the releasing agent. The dose-response curve of the rate-increasing effect of guanethidine began at a higher dose level, was steeper and had a higher maximum than that of reserpine. The maximally effective dose of guanethidine (mw 198) was 30 mg as compared to that of 3 mg for reserpine (mw 608.7). The amounts of norepinephrine released in about 2 hours by 10 to 30 mg of guanethidine and by 3 mg of reserpine, respectively, were of the same order of magnitude.

In the heart-lung preparation of reserpine-pretreated dogs, guanethidine, in the dose range of 1 to 10 mg, had no or very little rate-increasing effect. The dose of 6 mg caused a tenfold increase in the sensitivity of the pacemaker to administered norepinephrine. Reserpine, in a dose of 10 mg, had no sensitizing activity. In the absence of norepinephrine release, guanethidine, in a dose of 3 mg or more, impaired the force of contraction. In equimolar doses it had greater negative inotropic activity than reserpine.

In the intact rat, intraperitoneal injection of 20 mg of guanethidine per kg caused a depletion of the cardiac norepinephrine stores in about 5 hours. Replenishment of the stores required more than 3 days. An equipotent dose of reserpine of 5 mg/kg caused depletion in about 2 hours and replenishment required more than 6 days.

Submitted on July 10, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1962 by the American Society for Pharmacology and Experimental Therapeutics.